Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle



Rating:

Share or cite this content

Citations should be made in the following way:
R. D. Gray, M. Imrie, G. MacGregor, M. Dewar, A. C. Boyd, J. A. Innes, D. Porteous, A. P. Greening (Edinburgh, United Kingdom). New proteomic biomarkers of cystic fibrosis: a comparison with non-CF bronchiectasis. Eur Respir J 2005; 26: Suppl. 49, 1633

Member's Comments

No comment yet.

Related content which might interest you: Molecular detection of complex microbial communities in sputa of patients with cystic fibrosis and non cystic fibrosis bronchiectasis Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010 Phenotype characterization of non-cystic fibrosis bronchiectasis in India. Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies Year: 2017 NTM in cystic fibrosis and non-CF bronchiectasis Source: ERS Course 2015 Year: 2015 Global burden of non-cystic fibrosis bronchiectasis: A simple epidemiological analysis Source: Annual Congress 2012 - Epidemiology of various respiratory diseases Year: 2012 Inflammatuary markers in induced sputum and clinical parameters in children with non-cystic fibrosis bronchiectasis Source: Annual Congress 2004 - Chronic respiratory illness in childhood Year: 2004 The lung microbiome in chronic suppurative lung disease: cystic fibrosis and non-cystic fibrosis bronchiectasis Source: Eur Respir Monogr 2019; 83: 158-172 Year: 2019 Comparison of EBC biomarkers in cystic fibrosis and bacterial pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 191s Year: 2006 The pulmonary microbiome in non-cystic fibrosis bronchiectasis. Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies Year: 2017 Immuno-allertypes in non-cystic fibrosis  bronchiectasis Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018 Non-cystic fibrosis bronchiectasis Source: Eur Respir Monogr 2017; 77: 181-198 Year: 2017 Non-cystic fibrosis bronchiectasis Source: Eur Respir Monogr 2017; 77: 38-57 Year: 2017 Non-cystic fibrosis bronchiectasis Source: International Congress 2019 – Recent clinical advances in inhalation therapy Year: 2019 Non-cystic fibrosis bronchiectasis Source: Virtual Congress 2020 – Paediatric year in review Year: 2020 Proteomic analysis of sputum from adults with cystic fibrosis and COPD: identification of potential biomarkers for disease monitoring Source: Eur Respir J 2006; 28: Suppl. 50, 152s Year: 2006 Exercise capacity in patients with cystic fibrosis vs non-cystic fibrosis bronchiectasis Source: International Congress 2018 – Mechanisms that underlie exercise limitation in various respiratory diseases Year: 2018 A molecular comparison of microbial communities in bronchiectasis and cystic fibrosis Source: Eur Respir J 2013; 41: 991-993 Year: 2013 Cystic fibrosis patients have different microbiological colonization comparing to other bronchiectasis Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010 Non-cystic fibrosis bronchiectasis: series of 89 patients Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Non-cystic fibrosis bronchiectasis in children Source: Virtual Congress 2021 – Posters in paediatric bronchology Year: 2021